These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 24916103)
21. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells. Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling? Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634 [TBL] [Abstract][Full Text] [Related]
24. The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Pasini D; Bracken AP; Hansen JB; Capillo M; Helin K Mol Cell Biol; 2007 May; 27(10):3769-79. PubMed ID: 17339329 [TBL] [Abstract][Full Text] [Related]
25. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2. Liu F; He Y; Shu R; Wang S Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190 [TBL] [Abstract][Full Text] [Related]
27. Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification. Gherardi S; Ripoche D; Mikaelian I; Chanal M; Teinturier R; Goehrig D; Cordier-Bussat M; Zhang CX; Hennino A; Bertolino P Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):427-437. PubMed ID: 28215965 [TBL] [Abstract][Full Text] [Related]
28. Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma. Huang D; Wang X; Zhuang C; Shi W; Liu M; Tu Q; Zhang D; Hu L Oncol Rep; 2016 Feb; 35(2):1083-90. PubMed ID: 26718325 [TBL] [Abstract][Full Text] [Related]
29. EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma. Kusakabe Y; Chiba T; Oshima M; Koide S; Rizq O; Aoyama K; Ao J; Kaneko T; Kanzaki H; Kanayama K; Maeda T; Saito T; Nakagawa R; Kobayashi K; Kiyono S; Nakamura M; Ogasawara S; Suzuki E; Nakamoto S; Yasui S; Mikata R; Muroyama R; Kanda T; Maruyama H; Kato J; Mimura N; Ma A; Jin J; Zen Y; Otsuka M; Kaneda A; Iwama A; Kato N Sci Rep; 2021 Nov; 11(1):21396. PubMed ID: 34725436 [TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Yang F; Zhang L; Huo XS; Yuan JH; Xu D; Yuan SX; Zhu N; Zhou WP; Yang GS; Wang YZ; Shang JL; Gao CF; Zhang FR; Wang F; Sun SH Hepatology; 2011 Nov; 54(5):1679-89. PubMed ID: 21769904 [TBL] [Abstract][Full Text] [Related]
31. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription. Li Q; Li B; Dong C; Wang Y; Li Q Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088 [TBL] [Abstract][Full Text] [Related]
32. DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma. Zhang L; Li HT; Shereda R; Lu Q; Weisenberger DJ; O'Connell C; Machida K; An W; Lenz HJ; El-Khoueiry A; Jones PA; Liu M; Liang G Cancer Lett; 2022 Nov; 548():215899. PubMed ID: 36087682 [TBL] [Abstract][Full Text] [Related]
33. The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination. Kogure M; Takawa M; Saloura V; Sone K; Piao L; Ueda K; Ibrahim R; Tsunoda T; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R Neoplasia; 2013 Nov; 15(11):1251-61. PubMed ID: 24339737 [TBL] [Abstract][Full Text] [Related]
34. The polycomb group protein EZH2 inhibits lung cancer cell growth by repressing the transcription factor Nrf2. Li Z; Xu L; Tang N; Xu Y; Ye X; Shen S; Niu X; Lu S; Chen Z FEBS Lett; 2014 Aug; 588(17):3000-7. PubMed ID: 24928441 [TBL] [Abstract][Full Text] [Related]
35. Histone trimethylation of the p53 gene by expression of a constitutively active prolactin receptor in prostate cancer cells. Tan D; Tan S; Zhang J; Tang P; Huang J; Zhou W; Wu S Chin J Physiol; 2013 Oct; 56(5):282-90. PubMed ID: 24032713 [TBL] [Abstract][Full Text] [Related]
36. Regulation of Retinal Development via the Epigenetic Modification of Histone H3. Watanabe S; Murakami A Adv Exp Med Biol; 2016; 854():635-41. PubMed ID: 26427469 [TBL] [Abstract][Full Text] [Related]
37. Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2. Martin KA; Cesaroni M; Denny MF; Lupey LN; Tempera I Mol Cell Biol; 2015 Dec; 35(23):3934-44. PubMed ID: 26370511 [TBL] [Abstract][Full Text] [Related]
38. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques. Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221 [TBL] [Abstract][Full Text] [Related]
39. Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target. Agarwal P; Alzrigat M; Párraga AA; Enroth S; Singh U; Ungerstedt J; Österborg A; Brown PJ; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H Oncotarget; 2016 Feb; 7(6):6809-23. PubMed ID: 26755663 [TBL] [Abstract][Full Text] [Related]
40. Histone-modifying genes as biomarkers in hepatocellular carcinoma. Hung SY; Lin HH; Yeh KT; Chang JG Int J Clin Exp Pathol; 2014; 7(5):2496-507. PubMed ID: 24966962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]